Our Recommendations
- Surveillance Mpox. Protocole de notification pour les états membres de l'union Africaine (2024)
- Clinical features and management of human monkeypox: a retrospective observational study in the UK (2022)
- Hinweise zur Therapie von Affenpocken (2022)
- Laboratory testing for the monkeypox virus (2022)
- Surveillance, case investigation and contact tracing for monkeypox: interim guidance 24 June 2022 (2022)
New Publications
- Surveillance Mpox. Protocole de notification pour les états membres de l'union Africaine (2024)
- Mpox Surveillance Reporting Protocol for African Union Member States (2024)
- Tests rapides de détection antigéniques pour le diagnostic de mpox (2024)
- Statement on Antigen Rapid Tests for Mpox Diagnosis, 30 October 2024 (2024)
- Weekly special briefing on Mpox outbreak and other health emergencies in Africa (2025)
Filter
59
Featured
Recommendations
11
New Publications
4
Language
Document type
Guidelines
28
Studies & Reports
7
Fact sheets
6
No document type
6
Resource Platforms
5
Strategic & Response Plan
3
Situation Updates
2
Training Material
1
Infographics
1
Countries / Regions
Nigeria
5
Germany
2
Mozambique
1
Global
1
Congo, Democratic Republic of
1
United Kingdom
1
South Africa
1
Brazil
1
Angola
1
Pakistan
1
Authors & Publishers
Publication Years
Category
Clinical Guidelines
33
Countries
4
Key Resources
2
Pharmacy & Technologies
2
Public Health
1
Women & Child Health
1
WHO has updated the mpox Case reporting form (CRF) and data collection tool, mainly by reducing the number of variables. A detailed list of changes is presented in the file. The content of the Case investigation form (CIF) has not been changed.
Resource Platform
WHO invites Member States, health facilities and other entities to participate in the global effort to collect anonymized clinical data relating to suspected or confirmed cases of monkeypox and contribute data to the WHO Global Clinical Platform.
WHO has developed a clinical characterization case ...
Interim rapid response guidance, 10 June 2022.
It includes considerations for certain populations such as patients with mild disease with considerations for community care, patients with moderate to severe disease, sexually active persons, pregnant or breastfeeding women, children and young persons...
Interim rapid response guidance, 10 June 2022.
It includes considerations for certain populations such as patients with mild disease with considerations for community care, patients with moderate to severe disease, sexually active persons, pregnant or breastfeeding women, children and young persons...
19 August 2022. A monkeypox case investigation form (CIF) has been designed as a tool for Member States and researchers to conduct in-depth epidemiological investigation of suspected, probable and confirmed cases of monkeypox. This form allows to collect data prospectively or retrospectively for bot...
Nach dem derzeitigen Informationsstand sind aktuell humane Infektionen durch das Affenpockenvirus (monkeypox virus, MPX) in einigen Regionen der Welt einschließlich mehreren europäischen Ländern aufgetreten. Die Daten belegen eine Mensch-zu-Mensch-Übertragung unter bestimmten Bedingungen. Die Ü...
Updated August 2022
Clinical features and management of human monkeypox: a retrospective observational study in the UK
recommended
Cases of human monkeypox are rarely seen outside of west and central Africa. There are few data regarding viral kinetics or the duration of viral shedding and no licensed treatments. Two oral drugs, brincidofovir and tecovirimat, have been approved for treatment of smallpox and have demonstrated eff...
The Interim Guidance for Risk Communication and Community Engagement (RCCE) outlines recommendations, considerations and methods to raise awareness, manage risk perception, maintain trust and proactively support people at risk to make informed decisions to protect themselves and others from monkeypo...
Informationsplattform rund um Affenpocken
L’orthopoxvirus simien ou virus de la variole du singe (MPXV), est un virus à ADN double brin qui appartient au genre Orthopoxvirus de la famille
des Poxviridés. Les poxvirus causent des maladies chez l’espèce humaine et beaucoup d’autres animaux ; l’infection se manifeste généralement...
MEDBOX Issue Brief no.22, updated August 9, 2022
This document summarises the available data on MVA-BN (Imvanex) including from previous
experience of use of this vaccine in contacts of monkeypox cases in the UK and details the
current advice of an expert working group (see Appendix 1 for details) on the use of this vaccine
for pre- and post-ex...
